In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

I look forward to working with the team to reach new corporate and clinical milestones,” added Dieter Weinand, Chairman of ...

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025 ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...

In this way, these virtual biotechs are able to find a market for these compounds, since blockbusters and biosimilars are not as feasible for smaller biotech organizations. "The realities of the ...

At this year's South by Southwest (SXSW) conference in Austin, Texas, Future Today Strategy Group founder and CEO Amy Webb ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...